(Q40464515)

20 September 2017

title

Pamidronate treatment of less severe forms of osteogenesis imperfecta in children. (English)

1 reference

20 September 2017

main subject

osteogenesis imperfecta

0 references

author name string

Margaret Zacharin

series ordinal

1

1 reference

20 September 2017

Shankar Kanumakala

series ordinal

2

1 reference

20 September 2017

publication date

1 November 2004

1 reference

Journal of Pediatric Endocrinology and Metabolism

20 September 2017

published in

1 reference

20 September 2017

volume

17

1 reference

20 September 2017

issue

11

1 reference

20 September 2017

page(s)

1511-1517

1 reference

Osteogenesis imperfecta: translation of mutation to phenotype

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Mutations in type 1 procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

The crippling consequences of fractures and their impact on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Costs and health effects of osteoporotic fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

New uses of bisphosphonates: osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Molecular mechanisms of action of bisphosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Bisphosphonates: from the laboratory to the clinic and back again

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Bone mineral content and density in healthy subjects and in osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

The microscopic structure of bone in normal children and patients with osteogenesis imperfecta: a survey using backscattered electron imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

The contribution of reduced peak accrual of bone and age-related bone loss to osteoporosis at the spine and hip: insights from the daughters of women with vertebral or hip fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Evaluation of adverse health outcomes associated with vertebral fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Quality of life in osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

Bisphosphonates: from grandparents to grandchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.11.1511

10.1515/JPEM.2004.17.11.1511

21 January 2018

Identifiers

DOI

1 reference

release_abeygl55erenrgu7tteuurqveq

20 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/abeygl55erenrgu7tteuurqveq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference